Drug Patents owned by Sunovion Resp
1. List of Lonhala Magnair Kit drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7316067 | SUNOVION RESP | Forming a perforate membrane by laser drilling and a subsequent electro-polishing step |
Sep, 2022
(9 months ago) | |
| US8511581 | SUNOVION RESP | Fluid droplet production apparatus and method |
Nov, 2023
(4 months from now) | |
| US7458372 | SUNOVION RESP | Inhalation therapy device |
Nov, 2024
(1 year, 5 months from now) | |
| US7931212 | SUNOVION RESP | Fluid droplet production apparatus and method |
Nov, 2025
(2 years from now) | |
| US11278683 | SUNOVION RESP | Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized |
Aug, 2026
(3 years from now) | |
| US9265900 | SUNOVION RESP | Disposable ampoule for an aerosol generating device |
Dec, 2028
(5 years from now) | |
| US10940110 | SUNOVION RESP | Method and system for the treatment of chronic COPD with nebulized anticholinergic administrations |
Feb, 2029
(5 years from now) | |
| US9789270 | SUNOVION RESP | Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized |
Oct, 2030
(7 years from now) | |
| US9168556 | SUNOVION RESP | Membrane nebulizer and method for welding a membrane to a carrier during the production of a membrane nebulizer |
Sep, 2032
(9 years from now) | |
| US9604018 | SUNOVION RESP | Aerosol therapy device |
May, 2033
(9 years from now) | |
| US10376661 | SUNOVION RESP | Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element |
Sep, 2035
(12 years from now) | |
| US10688518 | SUNOVION RESP | Method of manufacturing a vibratable head for an aerosol generator and vibratable head for an aerosol generator |
Nov, 2036
(13 years from now) | |
| US10744277 | SUNOVION RESP | Aerosol delivery device and method of operating the aerosol delivery device |
Dec, 2036
(13 years from now) | |
Drugs and Companies using GLYCOPYRROLATE ingredient
Market Authorisation Date: 05 December, 2017
Treatment: Long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd); A method of using an aerosol delivery device to aerosolize glycopyrrolate for the ...
Dosage: SOLUTION;INHALATION
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic